Literature DB >> 32088350

Prevention as treatment: A bold vision for improving the cardiovascular health of people living with HIV.

Chris T Longenecker1, Allison R Webel2, Donald M Lloyd-Jones3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32088350      PMCID： PMC7881833          DOI： 10.1016/j.pcad.2020.02.011

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN： 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  8 in total

Review 1.  Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.

Authors:  Matthew J Feinstein; Priscilla Y Hsue; Laura A Benjamin; Gerald S Bloomfield; Judith S Currier; Matthew S Freiberg; Steven K Grinspoon; Jules Levin; Chris T Longenecker; Wendy S Post
Journal:  Circulation       Date:  2019-06-03       Impact factor: 29.690

2.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

3.  Provider perceptions of the value of same-day, electronic patient-reported measures for use in clinical HIV care.

Authors:  R J Fredericksen; J Tufano; J Ralston; J McReynolds; M Stewart; W B Lober; K H Mayer; W C Mathews; M J Mugavero; P K Crane; H M Crane
Journal:  AIDS Care       Date:  2016-05-29

4.  Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD).

Authors:  Nwora Lance Okeke; Allison R Webel; Hayden B Bosworth; Angela Aifah; Gerald S Bloomfield; Emily W Choi; Sarah Gonzales; Sarah Hale; Corrilynn O Hileman; Virginie Lopez-Kidwell; Charles Muiruri; Megan Oakes; Julie Schexnayder; Valerie Smith; Rajesh Vedanthan; Chris T Longenecker
Journal:  Am Heart J       Date:  2019-07-18       Impact factor: 4.749

5.  Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care.

Authors:  Daniel B Klein; Wendy A Leyden; Lanfang Xu; Chun R Chao; Michael A Horberg; William J Towner; Leo B Hurley; Julia L Marcus; Charles P Quesenberry; Michael J Silverberg
Journal:  Clin Infect Dis       Date:  2015-01-16       Impact factor: 9.079

6.  Ryan White HIV/AIDS Program Assistance and HIV Treatment Outcomes.

Authors:  Heather Bradley; Abigail H Viall; Pascale M Wortley; Antigone Dempsey; Heather Hauck; Jacek Skarbinski
Journal:  Clin Infect Dis       Date:  2015-08-30       Impact factor: 9.079

7.  Vascular disease and aging in HIV: Time to extend the treatment cascade.

Authors:  Chris T Longenecker
Journal:  Vasc Med       Date:  2018-08-13       Impact factor: 3.239

8.  Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis.

Authors:  Anoop S V Shah; Dominik Stelzle; Kuan Ken Lee; Eduard J Beck; Shirjel Alam; Sarah Clifford; Chris T Longenecker; Fiona Strachan; Shashwatee Bagchi; William Whiteley; Sanjay Rajagopalan; Shyamasundaran Kottilil; Harish Nair; David E Newby; David A McAllister; Nicholas L Mills
Journal:  Circulation       Date:  2018-09-11       Impact factor: 29.690
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.